Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Neurosteroids are endogenous steroids acting in the central nervous system. They participate in synaptic plasticity, memory and learning, Alzheimer's disease, and certain drug reward. Some mechanisms behind these effects are thought to be nongenomic, e.g., they modulate the function of the N-methyl-D-aspartate (NMDA) receptor complex. In this study, we used a Chinese hamster ovary cell line stably transfected with NMDA receptor constituents NR1/NR2B, to investigate the effects of nanomolar concentrations of the neurosteroids pregnenolone sulfate (PS) and pregnanolone sulfate (3␣5S) Neurosteroids are endogenous steroids that act as potent modulators at NMDA and GABA A receptors (Compagnone and Mellon, 2000). As a result, they may regulate important processes such as plasticity (Klangkalya, 2005), memory and learning (Shimizu et al., 2000), and neuroprotection and Alzheimer's disease (Weill-Engerer et al., 2002). Pregnenolone sulfate (PS) and pregnanolone sulfate (3␣5S) are neurosteroids that interact at distinct sites on the NMDA receptor complex to modulate its function Horak et al., 2004;Johansson et al., 2005b). This modulation may account for some of the rapid, nongenomic effects generated by these compounds in the central nervous system. Neurosteroids, and sulfated neurosteroids in particular, are present at relatively low concentrations in the rat brain (Higashi et al., 2003;Liu et al., 2003). Nonetheless, when PS is administered at femtomole concentrations by intracerebroventricular injection to rodents, processes involving the NMDA receptor are affected (Flood et al., 1995;Mathis et al., 1996;Meziane et al., 1996;Weaver et al., 1997). In contrast, in electrophysiological experiments, much higher (micromolar) concentrations of the steroids are required to achieve modulatory effects on recombinant NMDA receptors (Mukai et al., 2000;Malayev et al., 2002). In these studies, PS acted as a positive allosteric modulator, stimulating the agonistinduced response of NMDA receptor complexes composed of NR1/NR2A or NR1/NR2B subunits, whereas 3␣5S was inhibitory (Malayev et al., 2002). Similar effects of PS and 3␣5S at micromolar concentrations were found when Ca 2ϩ influx was measured in CHO cells stably expressing the NMDA receptor NR1/NR2B subtype (Mukai et al., 2000).Ifenprodil, a noncompetitive antagonist of the NMDA receptor that is selective for the NR2B subunit (Chenard and Menniti, 1999;Williams, 2001), is commonly used as a pharmacological tool. We recently published studies demonstrating that sulfated neurosteroids differentially affect the binding of ifenprodil to rat cortical membranes (Johansson and Le Greves, 2005;Johansson et al., 2005a
Neurosteroids are endogenous steroids acting in the central nervous system. They participate in synaptic plasticity, memory and learning, Alzheimer's disease, and certain drug reward. Some mechanisms behind these effects are thought to be nongenomic, e.g., they modulate the function of the N-methyl-D-aspartate (NMDA) receptor complex. In this study, we used a Chinese hamster ovary cell line stably transfected with NMDA receptor constituents NR1/NR2B, to investigate the effects of nanomolar concentrations of the neurosteroids pregnenolone sulfate (PS) and pregnanolone sulfate (3␣5S) Neurosteroids are endogenous steroids that act as potent modulators at NMDA and GABA A receptors (Compagnone and Mellon, 2000). As a result, they may regulate important processes such as plasticity (Klangkalya, 2005), memory and learning (Shimizu et al., 2000), and neuroprotection and Alzheimer's disease (Weill-Engerer et al., 2002). Pregnenolone sulfate (PS) and pregnanolone sulfate (3␣5S) are neurosteroids that interact at distinct sites on the NMDA receptor complex to modulate its function Horak et al., 2004;Johansson et al., 2005b). This modulation may account for some of the rapid, nongenomic effects generated by these compounds in the central nervous system. Neurosteroids, and sulfated neurosteroids in particular, are present at relatively low concentrations in the rat brain (Higashi et al., 2003;Liu et al., 2003). Nonetheless, when PS is administered at femtomole concentrations by intracerebroventricular injection to rodents, processes involving the NMDA receptor are affected (Flood et al., 1995;Mathis et al., 1996;Meziane et al., 1996;Weaver et al., 1997). In contrast, in electrophysiological experiments, much higher (micromolar) concentrations of the steroids are required to achieve modulatory effects on recombinant NMDA receptors (Mukai et al., 2000;Malayev et al., 2002). In these studies, PS acted as a positive allosteric modulator, stimulating the agonistinduced response of NMDA receptor complexes composed of NR1/NR2A or NR1/NR2B subunits, whereas 3␣5S was inhibitory (Malayev et al., 2002). Similar effects of PS and 3␣5S at micromolar concentrations were found when Ca 2ϩ influx was measured in CHO cells stably expressing the NMDA receptor NR1/NR2B subtype (Mukai et al., 2000).Ifenprodil, a noncompetitive antagonist of the NMDA receptor that is selective for the NR2B subunit (Chenard and Menniti, 1999;Williams, 2001), is commonly used as a pharmacological tool. We recently published studies demonstrating that sulfated neurosteroids differentially affect the binding of ifenprodil to rat cortical membranes (Johansson and Le Greves, 2005;Johansson et al., 2005a
Rationale The neurosteroid pregnenolone sulfate (PregS) acts as a cognitive enhancer and modulator of neurotransmission, yet aligning its pharmacological and physiological effects with reliable measurements of endogenous local concentrations and pharmacological and therapeutic targets has remained elusive for over 20 years. Objectives New basic and clinical research concerning neurosteroid modulation of the central nervous system (CNS) function has emerged over the past 5 years, including important data involving pregnenolone and various neurosteroid precursors of PregS that point to a need for a critical status update. Results Highly specific actions of PregS affecting excitatory N-methyl-D-aspartate receptor (NMDAR)-mediated synaptic transmission and the pharmacological effects of PregS on various receptors and ion channels are discussed. The discovery of a high potency (nanomolar) signal transduction pathway for PregS-induced NMDAR trafficking to the cell surface via a Ca2+- and G protein-coupled receptor (GPCR)-dependent mechanism and a potent (EC50 ~2 pM) direct enhancement of intracellular Ca2+ levels is discussed in terms of its agonist effects on long-term potentiation (LTP) and memory. Lastly, preclinical and clinical studies assessing the promnestic effects of PregS and pregnenolone toward cognitive dysfunction in schizophrenia, and altered serum levels in epilepsy and alcohol dependence, are reviewed. Conclusions PregS is present in human and rodent brain at physiologically relevant concentrations and meets most of the criteria for an endogenous neurotransmitter/neuromodulator. PregS likely plays a significant role in modulation of glutamatergic excitatory synaptic transmission underlying learning and memory, yet the molecular target(s) for its action awaits identification.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.